MYoroface AB is a Swedish company with a new approach to orofacial problems with the product IQoro®.
The company is founded in science and research and has the highest levels of academic approval and validation. It works with and in renowned hospital and research institutions to advance its knowledge and solutions.
IQoro® is often used by surviving stroke patients with swallowing problems, and also to address the following:
- Swallowing difficulties in any part of the chain from lips to stomach
- Reflux and hiatus hernia
- Speech difficulties caused by muscular impairment
Patients with such problems may be stroke survivors, have been born with chromosomatic disorders, be elderly, have had physical injury or be cancer sufferers or survivors.
IQoro® is a neuromuscular exerciser and regime that works by exercising the swallowing muscles and stimulating the brain circuits that control them. Patients self-administer at home, reducing HCP intervention and costs and reducing patient attendance at healthcare institutions to a minimum. No drugs are involved.
The exercise routine is simple and non-invasive and involves just three minutes’ exercise per day. Results are typically seen within a couple of weeks and full correction is usually achieved inside three months in successful interventions. Studies show that 97% of interventions have a positive result.
MYoroface is successful in Sweden with sales both to State Health Authorities, and directly to private patients. Distribution outside of Sweden is minimal at present, and MYoroface will be at Medica to promote international expansion.
Please make contact if you are established or interested in this area.